Archive for November 2023

Nasodine COVID-19 patent granted

HIGHLIGHTS  • Patent now granted in US, Australia and South Africa • Patent supports proposed nasal disinfection use of Nasodine Firebrick Pharma is pleased to announce that our patent covering the use of Nasodine® Nasal Spray in COVID-19 has now been granted in South Africa. The patent has previously been granted in the US and Australia…

Nasal disinfection as a front-line defence in future pandemics

Recently, Professor Peter Friedland presented at the Australian Military Medical Association conference (12 – 15 October 2023), with the title of his presentation being: “Nasal Disinfection as a Front-line Defence in Future Pandemics”. Read the published abstract here To view the full presentation, please click here Disclosure: the presentation is the view of the presenter…

Firebrick Investor Update